Managers / Q1 2023 · view latest →
ISZO CAPITAL MANAGEMENT LP
CIK 0001607925 · 590 MADISON AVENUE, 21ST FLOOR, NEW YORK, NY, 10022 · 646-775-4394
Summary
Iszo Capital Management LP reported $19M in U.S.-listed holdings across 10 positions for Q1 2023.
The portfolio is heavily concentrated: LNTH alone accounts for 43.9% of reported value.
Compared with Q4 2022, the fund opened 7 new positions and exited 4.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded, with multiple share classes and repeated sub-manager rows for the same issuer combined into one position — the same rule the holdings table uses by default. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- Common Stock · 58.5% · $11M
- ADR · 16.7% · $3M
- ETP · 13.6% · $3M
- Other · 11.2% · $2M
Quarter-over-Quarter Changes full breakdown →
vs Q4 2022 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| CBL & ASSOC PPTYS INC | NEW | +82.1K | 82.1K | +$2M | $2M |
| NVSNOVARTIS AG | NEW | +22.0K | 22.0K | +$2M | $2M |
| UTHRUNITED THERAPEUTICS CORP DEL | NEW | +9.0K | 9.0K | +$2M | $2M |
| QQQINVESCO QQQ TR | NEW | +4.8K | 4.8K | +$2M | $2M |
| NVONOVO-NORDISK A S | NEW | +7.0K | 7.0K | +$1M | $1M |
| SPYSPDR S&P 500 ETF TR | NEW | +2.5K | 2.5K | +$1M | $1M |
| FRCBFIRST REP BK SAN FRANCISCO C | NEW | +52.0K | 52.0K | +$727,480 | $727,480 |
| LNTHLANTHEUS HLDGS INC | ADDED | +82.9K | 100.0K | +$7M | $8M |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q1 2023
| # | Issuer | Class | % Portfolio | Value ↓ | Shares |
|---|---|---|---|---|---|
| 1 | LNTHLANTHEUS HLDGS INChistory → | COM | 43.89% | $8M | 100.0K |
| 2 | CBL & ASSOC PPTYS INC | COMMON STOCK | 11.19% | $2M | 82.1K |
| 3 | NVSNOVARTIS AGhistory → | SPONSORED ADR | 10.76% | $2M | 22.0K |
| 4 | UTHRUNITED THERAPEUTICS CORP DELhistory → | COM | 10.71% | $2M | 9.0K |
| 5 | QQQINVESCO QQQ TRhistory → | UNIT SER 1 | 8.19% | $2M | 4.8K |
| 6 | NVONOVO-NORDISK A Shistory → | ADR | 5.92% | $1M | 7.0K |
| 7 | SPYSPDR S&P 500 ETF TRhistory → | TR UNIT | 5.44% | $1M | 2.5K |
| 8 | FRCBFIRST REP BK SAN FRANCISCO Chistory → | COM | 3.87% | $727,480 | 52.0K |
| 9 | AMPYAMPLIFY ENERGY CORP NEW | COM | 0.03% | $6,547 | 953 |
| 10 | GLOBAL CORD BLOOD CORPORATIO | SHS | 0.00% | $0 | 279.5K |
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q4 2023 | $2M | 1 | Feb 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q3 2023 | $2M | 3 | Nov 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | $18M | 3 | Aug 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023 | $19M | 10 | May 15, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | $7M | 7 | Feb 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q3 2022 | $58M | 6 | Nov 14, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q2 2022 | $64M | 6 | Aug 15, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q1 2022 | $84M | 5 | May 16, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q4 2021 | $190M | 7 | Feb 14, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q3 2021 | $227M | 7 | Nov 12, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q2 2021 | $275M | 8 | Aug 16, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q1 2021 | $212M | 5 | May 17, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q4 2020 | $96M | 6 | Feb 16, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q3 2020 | $74M | 5 | Nov 17, 2020 | RESTATEMENT | changes · EDGAR ↗ |
| Q2 2020 | $57M | 10 | Aug 14, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q1 2020 | $65M | 10 | May 15, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q4 2019 | $69M | 3 | Feb 14, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q3 2019 | $76M | 4 | Nov 14, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q2 2019 | $64M | 2 | Aug 14, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q1 2019 | $61M | 5 | May 15, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q4 2018 | $92M | 5 | Feb 14, 2019 | 13F-HR | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.